杨贵妃传媒視頻

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 杨贵妃传媒視頻 Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Oct 28 2022

Full Issue

Walgreens Pharmacy Staff Will Be Allowed To Work More Slowly

NBC News reports that Walgreens is going to stop judging pharmacy staff performance on speed or "task-based metrics," with the pharmacy giant saying that evaluations will center on patient support and quality instead. Separately, a patient died in an Alzheimer's drug trial, sparking risk concerns.

Walgreens, the country鈥檚 second-largest pharmacy chain, announced Wednesday that it is eliminating 鈥渢ask-based metrics鈥 from performance evaluations to allow its pharmacy staffers to 鈥減lace even greater focus on patient care.鈥 They will now be evaluated 鈥渟olely on the behaviors that best support patient care and enhance the patient experience,鈥 Walgreens said in a news release. (Kaplan, 10/27)

In other pharmaceutical news 鈥

The experimental Alzheimer鈥檚 drug lecanemab, hailed after it slowed patients鈥 cognitive decline in a clinical trial, may have contributed to the death in June of a patient in the study, STAT has learned. (Mast, 10/28)

On drug use and addiction 鈥

Leading consulting firm McKinsey & Co has agreed to settle claims by hundreds of U.S. local governments and school districts around the country that it fueled an epidemic of opioid addiction through its work for bankrupt OxyContin maker Purdue Pharma LP and other drug companies. The deal was disclosed in a court filing Wednesday evening in San Francisco federal court. Its terms were not made public, and McKinsey and a lawyer for the settling plaintiffs did not immediately respond to requests for comment. (Pierson, 10/27)

A bill named after a 22-year-old Alaskan who died of a fentanyl overdose took a step forward this week, with companion legislation to a U.S. Senate proposal now introduced in the House. Robert 鈥淏ruce鈥 Snodgrass of Anchorage died in October 2021. In the year since, his mother helped advocate for legislation to spread awareness about deadly synthetic opioids like fentanyl. (Rogerson, 10/27)

Dana and John Pope had never heard of kratom before their 23-year-old son, Ethan, was found dead on the kitchen floor in his apartment last December with his puppy by his side. Extracted from the leaves of a tropical tree native to Southeast Asia, kratom is used to make capsules, powders and liquids and is marketed as an aid for pain, anxiety and drug dependence. In Georgia and some other states, it鈥檚 often sold at gas stations and smoke shops. ... The lawsuit was originally filed in May and an expanded version was filed earlier this week. The lawyers who filed the suit said they want to send a message that kratom is unsafe for human consumption. (Brumback, 10/27)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, June 1
  • Friday, May 29
  • Thursday, May 28
  • Wednesday, May 27
  • Tuesday, May 26
  • Friday, May 22
More Morning Briefings
RSS Feeds
  • 杨贵妃传媒視頻
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 KFF